With a revenue increase of 17.67% in the third quarter 2025, year on year to cumulative value of $331 million, Dynavax Technologies's revenue per employee grew on a trailing twelve months basis to $ 1,201,865, this is below the company average.
Within the Healthcare sector Employees of 92 other companies have achieved higher revenue per employee. While Dynavax Technologies's total ranking has deteriorated compared to the previous quarter from 611 to 649. Dynavax Technologies has 275 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DVAX Revenue per Employee	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Revenue Change	17.67 %	29.33 %	34.21 %	29.56 %	17.68 %
Sales per Employee (TTM) $	1,201,865	1,150,062	1,071,345	1,008,167	948,404
DVAX's Total Ranking	# 649	# 611	# 627	# 437	# 753
Seq. Revenue Change	-0.59 %	40.02 %	-5.37 %	-10.66 %	9.26 %

DVAX Company Profile >> Back to DVAX Efficiency Comparisons >> Compare DVAX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 54
Healthcare Sector	# 93
Overall Market	# 649

Revenue per Employee Statistics
High	Average	Low
$ 2,662,767	$ 578,738	$ 1,189
(Sep 30 2022)		(Dec 31 2017)

Financial Statements
Dynavax Technologies's Revenue MRQ	$ 95 Millions	Visit DVAX's Income Statement
Dynavax Technologies's Revenues TTM	$ 331 Millions	Visit DVAX's aggregate revenue growth
What are DVAX's Sales?		Visit DVAX's Sales by Segment

Other Ratios
Dynavax Technologies's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DVAX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DVAX's Competitors
Revenue per Employee for DVAX's Suppliers
Revenue per Employee for DVAX's Customers

You may also want to know
DVAX's Sales Growth Rates	DVAX's Pe Price to earnings ratio	DVAX's Receivables Turnover Ratio	DVAX's Stock Quote
DVAX's Net Income Growth Rates	DVAX's Ps Price to Sales ratio	DVAX's Sales per Employee	DVAX's Asset Turnover Ratio
DVAX's Net Margin	DVAX's Pb Price to Book ratio	DVAX's Financial Strength Ratios	DVAX's Dividend Payout Ratio

Date modified: 2026-08-29T17:19:47+00:00

Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Sep 30 2025	Number of Employees Sep 30 2025
Aurinia Pharmaceuticals Inc	2,076,625.00	$ 265.808 Million	128
Indivior Pharmaceuticals Inc	2,068,000.00	$ 2,068.000 Million	1,000
Exelixis Inc	1,994,959.02	$ 2,288.218 Million	1,147
Prestige Consumer Healthcare Inc	1,947,314.04	$ 1,109.969 Million	570
Elite Pharmaceuticals Inc	1,872,514.65	$ 121.713 Million	65
Evoke Pharma Inc	1,803,081.50	$ 14.425 Million	8
Ptc Therapeutics inc	1,795,307.77	$ 1,779.150 Million	991
Collegium Pharmaceutical Inc	1,786,827.42	$ 755.828 Million	423
Gilead Sciences Inc	1,711,000.00	$ 29,087.000 Million	17,000
Incyte Corporation	1,692,371.66	$ 4,813.105 Million	2,844
Privia Health Group Inc	1,666,043.23	$ 2,042.569 Million	1,226
Cytomx Therapeutics Inc	1,646,826.09	$ 113.631 Million	69
Kiniksa Pharmaceuticals International Plc	1,633,806.01	$ 597.973 Million	366
Anaptysbio Inc	1,629,490.38	$ 169.467 Million	104
Spero Therapeutics Inc	1,621,960.00	$ 40.549 Million	25
Rigel Pharmaceuticals Inc	1,621,126.44	$ 282.076 Million	174
Avadel Pharmaceuticals Plc	1,615,337.66	$ 248.762 Million	154
Eton Pharmaceuticals Inc	1,593,545.45	$ 70.116 Million	44
Protagonist Therapeutics inc	1,584,977.27	$ 209.217 Million	132
Progyny Inc	1,481,349.30	$ 1,268.035 Million	856
Bristol myers Squibb Company	1,477,969.23	$ 48,034.000 Million	32,500
Jazz Pharmaceuticals Plc	1,438,696.54	$ 4,157.833 Million	2,890
Xenetic Biosciences Inc	1,429,467.50	$ 2.859 Million	2
Novavax inc	1,421,429.91	$ 1,064.651 Million	749
Zevra Therapeutics Inc	1,383,409.84	$ 84.388 Million	61
Biocryst Pharmaceuticals Inc	1,378,887.36	$ 599.816 Million	435
Apellis Pharmaceuticals Inc	1,375,366.71	$ 1,016.396 Million	739
Keenova Therapeutics Plc	1,370,000.00	$ 2,192.000 Million	1,600
Biogen Inc	1,342,120.00	$ 10,065.900 Million	7,500
Neurocrine Biosciences Inc	1,341,350.00	$ 2,682.700 Million	2,000

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.